Healthcare · Pharmaceutical expenditure

Pharmaceutical expenditure in Germany in 2026

Germany's pharmaceutical expenditure in 2026 reached 2.35 % GDP of GDP—one of the highest rates globally (6 out of 197). This high share is driven by a strong pharmaceutical industry, rapid adoption of innovative drugs, and high per-capita consumption. The country ranks among the top pharmaceutical markets, reflecting both broad access to medicines and a substantial R&D base.

Data for 2026 · unit: % GDP
Position

Germany world ranking

#6 / 197

Country position on the scale from last to first place for this indicator.

DE
#6
#197#1
Trend

Change over time

Change in indicator over the available period.

1.90
1990
2.10
2000
2.20
2010
2.30
2020
2.35
2026

Values — % GDP

Related questions

People also search for

Other pages of the reference by this indicator.

Summary

Frequently asked questions

Pharmaceutical expenditure in Germany — how much?
Based on 2026 data — 2.35 % GDP. This is rank #6 out of 197 countries.
What is Germany's rank by Pharmaceutical expenditure?
Germany ranks #6 out of 197 countries in the world ranking by «Pharmaceutical expenditure».
How has Pharmaceutical expenditure changed in Germany?
Over the available period the indicator changed from 1.90 to 2.35 % GDP.